About Us

Archives






Skye Bioscience Appoints Kaitlyn Arsenault as Chief Financial Officer

Posted: October 5, 2021 at 6:08 pm


SAN DIEGO, CA, Oct. 05, 2021 (GLOBE NEWSWIRE) --  Skye Bioscience, Inc. (OTCQB: SKYE) (“Skye”), a biopharmaceutical company developing proprietary cannabinoid-derived molecules to treat diseases with significant unmet need, has appointed Kaitlyn Arsenault, CPA, as Chief Financial Officer. Ms. Arsenault brings over 14 years of experience in accounting, auditing, financial reporting, mergers and acquisitions, as well as business operations in the life science and technology sectors.

View original post here:
Skye Bioscience Appoints Kaitlyn Arsenault as Chief Financial Officer

Related Post

No Comments

No comments yet.

Sorry, the comment form is closed at this time.